Metropolitan Life Insurance Company (MetLife)’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,167
| Closed | -$8.58K | – | 2322 |
|
|
2023
Q4 | $8.58K | Hold |
1,167
| – | – | ﹤0.01% | 2226 |
|
|
2023
Q3 | $8.96K | Hold |
1,167
| – | – | ﹤0.01% | 2255 |
|
|
2023
Q2 | $11.8K | Buy |
+1,167
| New | +$11.8K | ﹤0.01% | 2213 |
|
|
2021
Q4 | – | Sell |
-2,814
| Closed | -$74.7K | – | 2806 |
|
|
2021
Q3 | $74.7K | Buy |
+2,814
| New | +$74.7K | ﹤0.01% | 2671 |
|